Related Experiment Video
Updated: Aug 19, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Management of carcinoma of the prostate
1Department of Urology, St George's Hospital, London.
Hospital Medicine (London, England : 1998)
|February 3, 2000
Abstract:
Every year in the UK nearly 10,000 men die from advanced prostate cancer. On average these individuals lose 9 years of their anticipated lifespan. The cumulative loss of expected life years therefore amounts to around 90,000 per annum, and many hundreds of thousands more retirement years are blighted or lost worldwide as a consequence of this very prevalent neoplasm.

